Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Regulatory News (APH)

  • This share is currently suspended. It was suspended at a price of 64.70
  • There is currently no data for APH

Notification of Major Holdings

18 Jun 2018 17:19

RNS Number : 7737R
Alliance Pharma PLC
18 June 2018
 

TR-1: Standard form for notification of major holdings

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Alliance Pharma PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Details of person subject to the notification obligation

Name

BlackRock, Inc.

City and country of registered office (if applicable)

Wilmington, DE, USA

4. Full name of shareholder(s) (if different from 3.)

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

15/06/2018

6. Date on which issuer notified (DD/MM/YYYY):

18/06/2018

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuer

Resulting situation on the date on which threshold was crossed or reached

5.01%

0.01%

5.02%

476,842,884

Position of previous notification (if

applicable)

4.98%

0.03%

5.02%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB0031030819

23,896,403

5.01%

SUBTOTAL 8. A

23,896,403

5.01%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdate

Exercise/Conversion Period

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

Securities Lending

5,913

0.00%

SUBTOTAL 8. B 1

5,913

0.00%

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdate

Exercise/Conversion Period

Physical or cash

settlement

Number of voting rights

% of voting rights

CFD

Cash

62,119

0.01%

SUBTOTAL 8.B.2

62,119

0.01%

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary)

X

Name

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

See Attachment

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

BlackRock Regulatory Threshold Reporting Team James Michael

020 7743 3650

 

 

Place of completion

12 Throgmorton Avenue, London, EC2N 2DL, U.K.

Date of completion

18 June, 2018

 

Section 9 Attachment

 

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

BlackRock, Inc.

BlackRock Holdco 2, Inc.

BlackRock Financial Management, Inc.

BlackRock International Holdings, Inc.

BR Jersey International Holdings L.P.

BlackRock Group Limited

BlackRock Investment Management (UK) Limited

BlackRock, Inc.

BlackRock Holdco 2, Inc.

BlackRock Financial Management, Inc.

BlackRock Holdco 4, LLC

BlackRock Holdco 6, LLC

BlackRock Delaware Holdings Inc.

BlackRock Fund Advisors

BlackRock, Inc.

BlackRock Holdco 2, Inc.

BlackRock Financial Management, Inc.

BlackRock Holdco 4, LLC

BlackRock Holdco 6, LLC

BlackRock Delaware Holdings Inc.

BlackRock Fund Advisors

BlackRock Institutional Trust Company, National Association

BlackRock, Inc.

BlackRock Holdco 2, Inc.

BlackRock Financial Management, Inc.

BlackRock International Holdings, Inc.

BR Jersey International Holdings L.P.

BlackRock Group Limited

BlackRock Advisors (UK) Limited

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAKKPFFXPEFF
Date   Source Headline
15th May 20257:00 amRNSCancellation - Alliance Pharma Plc
15th May 20257:00 amRNSCancellation of Trading
14th May 20253:30 pmRNSForm 8.3 - ALAPH LN
14th May 20253:29 pmRNSForm 8.3 - Alliance Pharma Plc
14th May 20253:25 pmRNSForm 8.3 - Alliance Pharma plc
14th May 20253:06 pmRNSForm 8.3 ALLIANCE PHARMA PLC
14th May 20251:50 pmRNSForm 8.3 - Alliance Pharma PLC
14th May 202510:35 amRNSForm 8.5 (EPT/RI) - Alliance Pharma plc
14th May 20259:46 amRNSForm 8.3 - Alliance Pharma PLC
14th May 20258:53 amGNWForm 8.5 (EPT/RI)-Alliance Pharma plc
14th May 20257:30 amRNSScheme of Arrangement Becomes Effective
14th May 20257:30 amRNSSuspension - Alliance Pharma plc
13th May 20253:30 pmRNSForm 8.3 - ALAPH LN
13th May 20253:29 pmRNSForm 8.3 - Alliance Pharma Plc
13th May 20253:25 pmRNSForm 8.3 - Alliance Pharma plc
13th May 20251:57 pmRNSForm 8.3 ALLIANCE PHARMA PLC
13th May 202510:20 amRNSForm 8.5 (EPT/RI) - Alliance Pharma plc
12th May 20253:30 pmRNSForm 8.3 - ALAPH LN
12th May 20253:00 pmRNSForm 8.3 ALLIANCE PHARMA PLC
12th May 20252:49 pmRNSCOURT SANCTION OF THE SCHEME OF ARRANGEMENT
12th May 202510:05 amRNSForm 8.5 (EPT/RI) - Alliance Pharma plc
9th May 20255:30 pmRNSAlliance Pharma
9th May 20253:30 pmRNSForm 8.3 - Alliance Pharma plc
9th May 20253:25 pmRNSForm 8.3 - Alliance Pharma plc
9th May 20252:26 pmRNSForm 8.3 ALLIANCE PHARMA PLC
9th May 202511:22 amRNSForm 8.3 - Alliance Pharma PLC 09.05.2025
9th May 202511:13 amGNWForm 8.3 - [ALLIANCE PHARMA PLC - 08 05 2025] - (CGWL)
9th May 202511:12 amRNSForm 8.5 (EPT/RI) - Alliance Pharma plc
8th May 20252:48 pmRNSForm 8.3 - ALLIANCE PHARMA PLC
8th May 202512:53 pmRNSForm 8.3 - Alliance Pharma PLC 08.05.2025
8th May 202512:02 pmRNSForm 8.3 - Alliance Pharma Plc
8th May 202510:14 amRNSForm 8.5 (EPT/RI) - Alliance Pharma plc
7th May 20253:30 pmRNSForm 8.3 - ALAPH LN
7th May 20253:07 pmRNSForm 8.3 ALLIANCE PHARMA PLC
7th May 20251:53 pmGNWForm 8.3 - [ALLIANCE PHARMA PLC - 06 05 2025] - (CGWL)
7th May 20251:37 pmRNSForm 8.3 - Alliance Pharma PLC 07.05.2025
7th May 202510:24 amRNSForm 8.5 (EPT/RI) - Alliance Pharma plc
6th May 20253:30 pmRNSForm 8.3 - ALAPH
6th May 20253:25 pmRNSForm 8.3 - Alliance Pharma plc
6th May 20253:16 pmRNSForm 8.3 - Alliance Pharma Plc
6th May 20253:15 pmRNSForm 8.3 ALLIANCE PHARMA PLC
6th May 20259:59 amRNSForm 8.5 (EPT/RI) - Alliance Pharma plc
2nd May 20253:30 pmRNSForm 8.3 - ALAPH LN
2nd May 20253:30 pmRNSForm 8.3 - ALAPH
2nd May 20252:56 pmRNSForm 8.3 ALLIANCE PHARMA PLC
2nd May 202510:11 amRNSForm 8.3 - ALLIANCE PHARMA PLC
2nd May 202510:07 amRNSForm 8.5 (EPT/RI) - Alliance Pharma plc
1st May 20253:36 pmRNSNotification of Major Holdings
1st May 20253:25 pmRNSForm 8.3 - Alliance Pharma plc
1st May 20252:02 pmRNSForm 8.3 - Alliance Pharma PLC 01.05.2025

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.